Schizophrenia, amphetamine-induced sensitized state and acute amphetamine exposure all show a common alteration: Increased dopamine D2 receptor dimerization

Molecular Brain

Volumn 3, Issue 1, 2010, Pages

  Wang, Min ^a   Pei, Lin ^a   Fletcher, Paul J ^a,c   Kapur, Shitij ^b   Seeman, Philip ^c   Liu, Fang ^a,c  

^a CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHETAMINE; DIMER; DOPAMINE 2 RECEPTOR; DOPAMINE TRANSPORTER; HALOPERIDOL; MONOMER; DOPAMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOPSY; BINDING ASSAY; BIPOLAR DISORDER; CONTROLLED STUDY; DEPRESSION; DIMERIZATION; DRUG SENSITIZATION; EMBRYO; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPRECIPITATION; LIGAND BINDING; MALE; MENTAL PATIENT; NONHUMAN; OSMOTIC PUMP; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; RAT; RECEPTOR UPREGULATION; SCHIZOPHRENIA; STRIATE CORTEX; WESTERN BLOTTING; AGED; ANIMAL; CADAVER; CELL CULTURE; CHEMISTRY; DRUG EFFECT; METABOLISM; NEOSTRIATUM; NERVE CELL; PATHOLOGY; PROTEIN BINDING; PROTEIN MULTIMERIZATION; SPRAGUE DAWLEY RAT; UPREGULATION;

ANIMALIA; RATTUS;

AGED; AMPHETAMINE; ANIMALS; CELLS, CULTURED; DOPAMINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; HUMANS; NEOSTRIATUM; NEURONS; POSTMORTEM CHANGES; PROTEIN BINDING; PROTEIN MULTIMERIZATION; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE D2; SCHIZOPHRENIA; UP-REGULATION;

EID: 77956478769     PISSN: None     EISSN: 17566606     Source Type: Journal    
DOI: 10.1186/1756-6606-3-25     Document Type: Article

References (50)

1. Neuroreceptor imaging in psychiatric disorders. WG Frankle M Laruelle, Ann Nucl Med 2002 16 437 446 10.1007/BF02988639 12508833
2. Schizophrenia: more dopamine, more D2 receptors. P Seeman S Kapur, Proc Natl Acad Sci USA 2000 97 7673 7675 10.1073/pnas.97.14.7673 10884398
3. Increased caudate dopamine D2 receptor availability as a genetic marker for schizophrenia. J Hirvonen TG van Erp J Huttunen S Aalto K Nagren M Huttunen J Lonnqvist J Kaprio J Hietala TD Cannon, Arch Gen Psychiatry 2005 62 371 378 10.1001/archpsyc.62.4.371 15809404
4. The dopamine hypothesis of schizophrenia: version III - the final common pathway. OD Howes S Kapur, Schizophr Bull 2009 35 549 562 10.1093/schbul/sbp006 19325164
5. G-protein-coupled receptor oligomerization and its potential for drug discovery. SR George BF O'Dowd SP Lee, Nat Rev Drug Discov 2002 1 808 820 10.1038/nrd913 12360258
6. Agonist occupancy of a single monomeric element is sufficient to cause internalization of the dimeric beta2-adrenoceptor. N Sartania S Appelbe JD Pediani G Milligan, Cell Signal 2007 19 1928 1938 10.1016/j.cellsig.2007.05.002 17561373
7. CXCR2 chemokine receptor antagonism enhances DOP opioid receptor function via allosteric regulation of the CXCR2-DOP receptor heterodimer. G Parenty S Appelbe G Milligan, Biochem J 2008 412 245 256 10.1042/BJ20071689 18307412
8. Conformational cross-talk between alpha2A-adrenergic and mu-opioid receptors controls cell signaling. JP Vilardaga VO Nikolaev K Lorenz S Ferrandon Z Zhuang MJ Lohse, Nat Chem Biol 2008 4 126 131 10.1038/nchembio.64 18193048
9. A division of labor: asymmetric roles for GPCR subunits in receptor dimers. P Zylbergold TE Hebert, Nat Chem Biol 2009 5 608 609 10.1038/nchembio0909-608 19690532
10. Crosstalk between GABA(B) and mGlu1a receptors reveals new insight into GPCR signal integration. ML Rives C Vol Y Fukazawa N Tinel E Trinquet MA Ayoub R Shigemoto JP Pin L Prezeau, EMBO J 2009 28 2195 2208 10.1038/emboj.2009.177 19590495
11. Evidence for the existence of receptor - receptor interactions in the central nervous system. Studies on the regulation of monoamine receptors by neuropeptides. K Fuxe LF Agnati F Benfenati M Celani I Zini M Zoli V Mutt, J Neural Transm Suppl 1983 18 165 179 6192208
12. Phosphorylation and palmitoylation of the human D2L dopamine receptor in Sf9 cells. GY Ng BF O'Dowd M Caron M Dennis MR Brann SR George, J Neurochem 1994 63 1589 1595 10.1046/j.1471-4159.1994.63051589.x 7931316
13. Dopamine D2 receptor dimers and receptor-blocking peptides. GY Ng BF O'Dowd SP Lee HT Chung MR Brann P Seeman SR George, Biochem Biophys Res Commun 1996 227 200 204 10.1006/bbrc.1996.1489 8858125
14. Dopamine D2 receptor dimers in human and rat brain. P Zawarynski T Tallerico P Seeman SP Lee BF O'Dowd SR George, FEBS Lett 1998 441 383 386 10.1016/S0014-5793(98)01588-9 9891976
15. Neurotransmitter receptor heteromers in neurodegenerative diseases and neural plasticity. R Franco, J Neural Transm 2009 116 983 987 10.1007/s00702-008-0148-y 19002553
16. Receptor-receptor interactions within receptor mosaics. Impact on neuropsychopharmacology. K Fuxe D Marcellino A Rivera Z Diaz-Cabiale M Filip B Gago DC Roberts U Langel S Genedani L Ferraro, et al. Brain Res Rev 2008 58 415 452 10.1016/j.brainresrev.2007.11.007 18222544
17. Dopamine D2 receptor dimer formation: evidence from ligand binding. D Armstrong PG Strange, J Biol Chem 2001 276 22621 22629 10.1074/jbc.M006936200 11278324
18. The cloned dopamine D2 receptor reveals different densities for dopamine receptor antagonist ligands. Implications for human brain positron emission tomography. P Seeman HC Guan O Civelli HH Van Tol RK Sunahara HB Niznik, Eur J Pharmacol 1992 227 139 146 10.1016/0922-4106(92)90121-B 1358662
19. The stanley foundation brain collection and neuropathology consortium. EF Torrey M Webster M Knable N Johnston RH Yolken, Schizophr Res 2000 44 151 155 10.1016/S0920-9964(99)00192-9 10913747
20. Differential effects of within-day continuous vs. transient dopamine D2 receptor occupancy in the development of vacuous chewing movements (VCMs) in rats. P Turrone G Remington S Kapur JN Nobrega, Neuropsychopharmacology 2003 28 1433 1439 10.1038/sj.npp.1300233 12838271
21. Direct protein-protein coupling enables cross-talk between dopamine D5 and gamma-aminobutyric acid A receptors. F Liu Q Wan ZB Pristupa XM Yu YT Wang HB Niznik, Nature 2000 403 274 280 10.1038/35001232 10659839
22. Dual regulation of NMDA receptor functions by direct protein-protein interactions with the dopamine D1 receptor. FJ Lee S Xue L Pei B Vukusic N Chery Y Wang YT Wang HB Niznik XM Yu F Liu, Cell 2002 111 219 230 10.1016/S0092-8674(02)00962-5 12408866
23. Dopamine receptor parameters detected by [3H]spiperone depend on tissue concentration: analysis and examples. P Seeman C Ulpian KA Wreggett JW Wells, J Neurochem 1984 43 221 235 10.1111/j.1471-4159.1984.tb06700.x 6726248
24. Dopamine displaces [3H]domperidone from high-affinity sites of the dopamine D2 receptor, but not [3H]raclopride or [3H]spiperone in isotonic medium: Implications for human positron emission tomography. P Seeman T Tallerico F Ko, Synapse 2003 49 209 215 10.1002/syn.10232 12827639
25. Treatment of ischemic brain damage by perturbing NMDA receptor-PSD-95 protein interactions. M Aarts Y Liu L Liu S Besshoh M Arundine JW Gurd YT Wang MW Salter M Tymianski, Science 2002 298 846 850 10.1126/science.1072873 12399596
26. The amphetamine-induced sensitized state as a model of schizophrenia. RE Featherstone S Kapur PJ Fletcher, Prog Neuropsychopharmacol Biol Psychiatry 2007 31 1556 1571 10.1016/j.pnpbp.2007.08.025 17884274
27. Psychosis pathways converge via D2high dopamine receptors. P Seeman J Schwarz JF Chen H Szechtman M Perreault GS McKnight JC Roder R Quirion P Boksa LK Srivastava, et al. Synapse 2006 60 319 346 10.1002/syn.20303 16786561
28. Clinical features of sensitization to methamphetamine observed in patients with methamphetamine dependence and psychosis. H Ujike M Sato, Ann N Y Acad Sci 2004 1025 279 287 10.1196/annals.1316.035 15542728
29. Increased dopamine D2(High) receptors in amphetamine-sensitized rats, measured by the agonist [(3)H](+)PHNO. P Seeman PN McCormick S Kapur, Synapse 2007 61 263 267 10.1002/syn.20367 17318886
30. Dopamine transporter cell surface localization facilitated by a direct interaction with the dopamine D2 receptor. FJ Lee L Pei A Moszczynska B Vukusic PJ Fletcher F Liu, EMBO J 2007 26 2127 2136 10.1038/sj.emboj.7601656 17380124
31. Studies on the distinction between uptake inhibition and release of (3H)dopamine in rat brain tissue slices. RE Heikkila H Orlansky G Cohen, Biochem Pharmacol 1975 24 847 852 10.1016/0006-2952(75)90152-5 1125084
32. Mechanisms of amphetamine action revealed in mice lacking the dopamine transporter. SR Jones RR Gainetdinov RM Wightman MG Caron, J Neurosci 1998 18 1979 1986 9482784
33. Amphetamine: effects on catecholamine systems and behavior. LS Seiden KE Sabol GA Ricaurte, Annu Rev Pharmacol Toxicol 1993 33 639 677 10.1146/annurev.pa.33.040193.003231 8494354
34. D1 and D2 dopamine receptor expression is regulated by direct interaction with the chaperone protein calnexin. RB Free LA Hazelwood DM Cabrera HN Spalding Y Namkung ML Rankin DR Sibley, J Biol Chem 2007 282 21285 21300 10.1074/jbc.M701555200 17395585
35. Dopamine D1 and D2 receptor Co-activation generates a novel phospholipase C-mediated calcium signal. SP Lee CH So AJ Rashid G Varghese R Cheng AJ Lanca BF O'Dowd SR George, J Biol Chem 2004 279 35671 35678 10.1074/jbc.M401923200 15159403
36. D1-D2 dopamine receptor heterooligomers with unique pharmacology are coupled to rapid activation of Gq/11 in the striatum. AJ Rashid CH So MM Kong T Furtak M El-Ghundi R Cheng BF O'Dowd SR George, Proc Natl Acad Sci USA 2007 104 654 659 10.1073/pnas.0604049104 17194762
37. D2/D3 dopamine receptor heterodimers exhibit unique functional properties. M Scarselli F Novi E Schallmach R Lin A Baragli A Colzi N Griffon GU Corsini P Sokoloff R Levenson, et al. J Biol Chem 2001 276 30308 30314 10.1074/jbc.M102297200 11373283
38. Receptors for dopamine and somatostatin: formation of hetero-oligomers with enhanced functional activity. M Rocheville DC Lange U Kumar SC Patel RC Patel YC Patel, Science 2000 288 154 157 10.1126/science.288.5463.154 10753124
39. Coaggregation, cointernalization, and codesensitization of adenosine A2A receptors and dopamine D2 receptors. J Hillion M Canals M Torvinen V Casado R Scott A Terasmaa A Hansson S Watson ME Olah J Mallol, et al. J Biol Chem 2002 277 18091 18097 10.1074/jbc.M107731200 11872740
40. G protein-coupled receptors form stable complexes with inwardly rectifying potassium channels and adenylyl cyclase. N Lavine N Ethier JN Oak L Pei F Liu P Trieu RV Rebois M Bouvier TE Hebert HH Van Tol, J Biol Chem 2002 277 46010 46019 10.1074/jbc.M205035200 12297500
41. D2 and D3 dopamine receptor cell surface localization mediated by interaction with protein 4.1N. AV Binda N Kabbani R Lin R Levenson, Mol Pharmacol 2002 62 507 513 10.1124/mol.62.3.507 12181426
42. Modulation of dopamine D(2) receptor signaling by actin-binding protein (ABP-280). M Li JC Bermak ZW Wang QY Zhou, Mol Pharmacol 2000 57 446 452 10692483
43. Association of the D2 dopamine receptor third cytoplasmic loop with spinophilin, a protein phosphatase-1-interacting protein. FD Smith GS Oxford SL Milgram, J Biol Chem 1999 274 19894 19900 10.1074/jbc.274.28.19894 10391935
44. Interactions of GIPC with dopamine D2, D3 but not D4 receptors define a novel mode of regulation of G protein-coupled receptors. F Jeanneteau J Diaz P Sokoloff N Griffon, Mol Biol Cell 2004 15 696 705 10.1091/mbc.E03-05-0293 14617818
45. Regulation of dense core vesicle release from PC12 cells by interaction between the D2 dopamine receptor and calcium-dependent activator protein for secretion (CAPS). AV Binda N Kabbani R Levenson, Biochem Pharmacol 2005 69 1451 1461 10.1016/j.bcp.2005.02.015 15857609
46. D2 dopamine receptor expression and trafficking is regulated through direct interactions with ZIP. OJ Kim MA Ariano Y Namkung P Marinec E Kim J Han DR Sibley, J Neurochem 2008 106 83 95 10.1111/j.1471-4159.2008.05348.x 18346199
47. Interaction with neuronal calcium sensor NCS-1 mediates desensitization of the D2 dopamine receptor. N Kabbani L Negyessy R Lin P Goldman-Rakic R Levenson, J Neurosci 2002 22 8476 8486 12351722
48. Schizophrenia model of elevated D2(High) receptors: haloperidol reverses the amphetamine-induced elevation in dopamine D2(High). P Seeman, Schizophr Res 2009 109 191 192 10.1016/j.schres.2008.12.024 19171464
49. Dopamine supersensitivity correlates with D2High states, implying many paths to psychosis. P Seeman D Weinshenker R Quirion LK Srivastava SK Bhardwaj DK Grandy RT Premont TD Sotnikova P Boksa M El-Ghundi, et al. Proc Natl Acad Sci USA 2005 102 3513 3518 10.1073/pnas.0409766102 15716360
50. D2 dopamine receptor homodimerization is mediated by multiple sites of interaction, including an intermolecular interaction involving transmembrane domain 4. SP Lee BF O'Dowd RD Rajaram T Nguyen SR George, Biochemistry 2003 42 11023 11031 10.1021/bi0345539 12974638